Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ZTS – Zoetis Inc.

Zoetis Inc.
ZTS
$113.35
Name : Zoetis Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $49,952,575,488.00
EPSttm : 6.02
finviz dynamic chart for ZTS
Zoetis Inc.
$113.35
2.81%
$3.28
ZTS — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

3.73

Margin Of Safety %

8

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.42

EPS Last/This Y

0.62

EPS This/Next Y

0.52

Price

113.38

Target Price

149.73

Analyst Recom

1.91

Performance Q

-9.67

Upside

16.8%

Beta

0.98

Ticker: ZTS



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-02ZTS128.980.320.6861126
2026-03-03ZTS125.960.331.1261299
2026-03-04ZTS125.90.331.6961700
2026-03-05ZTS122.220.321.3061679
2026-03-06ZTS121.450.322.7361258
2026-03-09ZTS122.350.331.0861709
2026-03-10ZTS120.480.340.7262406
2026-03-11ZTS119.80.341.1662436
2026-03-12ZTS115.460.342.7562386
2026-03-13ZTS115.460.343.1662386
2026-03-17ZTS121.660.360.5465989
2026-03-18ZTS117.380.352.0566617
2026-03-19ZTS116.020.350.7966617
2026-03-20ZTS115.640.340.6265948
2026-03-23ZTS115.270.270.1253147
2026-03-24ZTS115.950.260.6354744
2026-03-25ZTS116.730.260.2055274
2026-03-26ZTS116.620.261.3355923
2026-03-27ZTS113.330.273.2056194
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-02ZTS128.989.849.27.02
2026-03-03ZTS125.979.526.57.03
2026-03-04ZTS125.989.5103.47.03
2026-03-05ZTS122.219.55.17.03
2026-03-06ZTS121.429.581.07.03
2026-03-09ZTS122.359.5126.77.03
2026-03-10ZTS120.489.552.27.03
2026-03-11ZTS119.839.584.57.03
2026-03-12ZTS115.469.5-15.07.03
2026-03-13ZTS115.679.5108.07.03
2026-03-17ZTS121.659.5198.17.03
2026-03-18ZTS117.389.5-12.77.03
2026-03-19ZTS116.019.55.67.03
2026-03-20ZTS115.679.632.77.03
2026-03-23ZTS115.279.631.07.03
2026-03-24ZTS115.939.661.27.03
2026-03-25ZTS116.739.663.97.03
2026-03-26ZTS116.649.640.17.03
2026-03-27ZTS113.389.6-46.67.03
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-02ZTS-2.31-1.293.88
2026-03-03ZTS-2.31-1.293.88
2026-03-04ZTS-2.31-1.293.88
2026-03-05ZTS-2.31-1.293.88
2026-03-06ZTS-2.31-1.293.88
2026-03-09ZTS-2.31-1.173.88
2026-03-10ZTS-2.31-1.173.88
2026-03-11ZTS-2.31-1.174.11
2026-03-12ZTS-2.31-1.174.11
2026-03-13ZTS-2.31-1.174.11
2026-03-17ZTS-2.31-0.874.11
2026-03-18ZTS-2.31-0.874.11
2026-03-19ZTS-2.31-0.874.11
2026-03-20ZTS-2.31-0.874.11
2026-03-23ZTS-2.31-1.244.11
2026-03-24ZTS-2.31-1.244.11
2026-03-25ZTS-2.31-1.243.73
2026-03-26ZTS-2.31-1.243.73
2026-03-27ZTS-2.31-1.243.73
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

1.48

Avg. EPS Est. Current Quarter

1.62

Avg. EPS Est. Next Quarter

1.9

Insider Transactions

-2.31

Institutional Transactions

-1.24

Beta

0.98

Average Sales Estimate Current Quarter

2313

Average Sales Estimate Next Quarter

2560

Fair Value

122.56

Quality Score

95

Growth Score

84

Sentiment Score

42

Actual DrawDown %

54.5

Max Drawdown 5-Year %

-53.4

Target Price

149.73

P/E

18.82

Forward P/E

15

PEG

1.77

P/S

5.05

P/B

14.46

P/Free Cash Flow

20.96

EPS

6.02

Average EPS Est. Cur. Y​

7.03

EPS Next Y. (Est.)

7.54

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

28.23

Relative Volume

0.8

Return on Equity vs Sector %

52.9

Return on Equity vs Industry %

73.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

-46.6
◆ ZTS Healthcare
$113.35
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
13/25
Volume
7/15
Valuation
18/20
TP/AR
1/10
Options
5/10
RSI
34.3
Range 1M
3.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
32 /100
WEAK
Momentum
9/25
Growth
11/30
Estimates
6/20
Inst/Vol
0/15
Options
6/10
EPS Yr
9.5%
EPS NY
7.7%
52W%
1%
💎
Long-Term Value
Quality companies, undervalued
62 /100
WATCH
🟢 BUY +32% upside
Quality
30/30
Valuation
13/30
Growth
9/25
Stability
6/10
LT Trend
4/5
Upside
+32%
Quality
95
MoS
8%
Click a card to see score breakdown Full Analysis →
Zoetis Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 14500
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
ZTS

Latest News

—
Caricamento notizie per ZTS…
stock quote shares ZTS – Zoetis Inc. Stock Price stock today
news today ZTS – Zoetis Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ZTS – Zoetis Inc. yahoo finance google finance
stock history ZTS – Zoetis Inc. invest stock market
stock prices ZTS premarket after hours
ticker ZTS fair value insiders trading